[Dopamine Transporter SPECT with I-123 labelled FP-CIT (DaTSCANTM)].

Tatsch, Klaus; Buchert, Ralph; Bartenstein, Peter; Barthel, Henryk; Boecker, Henning; Brust, Peter; Drzezga, Alexander; la Fougère, Christian; Gründer, Gerhard; Grünwald, Frank; Krause, Bernd-J.; Kuwert, Torsten; Langen, Karl-Josef; Rominger, Axel Oliver; Sabri, Osama; Schreckenberger, Mathias; Meyer, Philipp T. (2019). [Dopamine Transporter SPECT with I-123 labelled FP-CIT (DaTSCANTM)]. Nuklearmedizin, 58(01), pp. 5-16. Thieme 10.1055/a-0807-8137

[img] Text
a-0807-8137.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (707kB) | Request a copy

The aim of the S1 guideline is to assist in establishing the indication and in performing, interpreting and reporting SPECT investigations of the dopamine transporter (DAT) with DaTSCANTM. Compared to the preceding version dated from 2007 the current update considers relevant new publications, the guidelines of the European (EANM) and Society of Nuclear Medicine (SNM), and the current version of the S3 guideline of the German Society of Neurology on "Idiopathic Parkinsonsian Syndrome". In addition new technical developments are incorporated.

Item Type:

Journal Article (Review Article)

Division/Institute:

04 Faculty of Medicine > Department of Radiology, Neuroradiology and Nuclear Medicine (DRNN) > Clinic of Nuclear Medicine

UniBE Contributor:

Rominger, Axel Oliver

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0029-5566

Publisher:

Thieme

Language:

English

Submitter:

Sabine Lanz

Date Deposited:

31 May 2019 15:01

Last Modified:

10 Mar 2020 10:20

Publisher DOI:

10.1055/a-0807-8137

PubMed ID:

30769368

BORIS DOI:

10.7892/boris.127560

URI:

https://boris.unibe.ch/id/eprint/127560

Actions (login required)

Edit item Edit item
Provide Feedback